|
1
|
Di Marzo V: Targeting the endocannabinoid
system: to enhance or reduce? Nat Rev Drug Discov. 7:438–455.
2008.
|
|
2
|
Greenhough A, Patsos HA, Williams AC and
Paraskeva C: The cannabinoid delta(9)-tetrahydrocannabinol inhibits
RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated
apoptosis in colorectal cancer cells. Int J Cancer. 121:2172–2180.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang D, Wang H, Ning W, Backlund MG, Dey
SK and DuBois RN: Loss of cannabinoid receptor 1 accelerates
intestinal tumor growth. Cancer Res. 68:6468–6476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patsos HA, Hicks DJ, Dobson RR, et al: The
endogenous cannabinoid, anandamide, induces cell death in
colorectal carcinoma cells: a possible role for cyclooxygenase 2.
Gut. 54:1741–1750. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ligresti A, Bisogno T, Matias I, et al:
Possible endocannabinoid control of colorectal cancer growth.
Gastroenterology. 125:677–687. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Izzo AA and Camilleri M: Cannabinoids in
intestinal inflammation and cancer. Pharmacol Res. 60:117–125.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Howlett AC, Barth F, Bonner TI, et al:
International Union of Pharmacology. XXVII Classification of
cannabinoid receptors. Pharmacol Rev. 54:161–202. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wright K, Rooney N, Feeney M, et al:
Differential expression of cannabinoid receptors in the human
colon: cannabinoids promote epithelial wound healing.
Gastroenterology. 129:437–453. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bedoya F, Rubio JC, Morales-Gutierrez C,
et al: Single nucleotide change in the cannabinoid receptor-1
(CNR1) gene in colorectal cancer outcome. Oncology. 76:435–441.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chung SC, Hammarsten P, Josefsson A, et
al: A high cannabinoid CB(1) receptor immunoreactivity is
associated with disease severity and outcome in prostate cancer.
Eur J Cancer. 45:174–182. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Michalski CW, Oti FE, Erkan M, et al:
Cannabinoids in pancreatic cancer: correlation with survival and
pain. Int J Cancer. 122:742–750. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu X, Liu Y, Huang S, et al:
Overexpression of cannabinoid receptors CB1 and CB2 correlates with
improved prognosis of patients with hepatocellular carcinoma.
Cancer Genet Cytogenet. 171:31–38. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gustafsson SB, Palmqvist R, Henriksson ML,
et al: High tumour cannabinoid CB1 receptor immunoreactivity
negatively impacts disease-specific survival in stage II
microsatellite stable colorectal cancer. PLoS One. 6:e230032011.
View Article : Google Scholar
|
|
14
|
Edge S, Byrd D, Compton C, Fritz A, Greene
F and Trotti A: AJCC Cancer Staging Manual. Springer; New York:
2010
|
|
15
|
Jass JR and Sobin LH: Histological Typing
of Intestinal Tumours WHO International Histological Classification
of Tumours. 2nd edition. Springer-Verlag; Berlin-New York: 1989,
View Article : Google Scholar
|
|
16
|
Cianchi F, Papucci L, Schiavone N, et al:
Cannabinoid receptor activation induces apoptosis through tumor
necrosis factor alpha-mediated ceramide de novo synthesis in colon
cancer cells. Clin Cancer Res. 14:7691–7700. 2008. View Article : Google Scholar
|
|
17
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
18
|
Galon J, Costes A, Sanchez-Cabo F, et al:
Type, density, and location of immune cells within human colorectal
tumors predict clinical outcome. Science. 313:1960–1964. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Naito Y, Saito K, Shiiba K, et al:
CD8+ T cells infiltrated within cancer cell nests as a
prognostic factor in human colorectal cancer. Cancer Res.
58:3491–3494. 1998.PubMed/NCBI
|
|
20
|
Ropponen KM, Eskelinen MJ, Lipponen PK,
Alhava E and Kosma VM: Prognostic value of tumour-infiltrating
lymphocytes (TILs) in colorectal cancer. J Pathol. 182:318–324.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Massa F, Marsicano G, Hermann H, et al:
The endogenous cannabinoid system protects against colonic
inflammation. J Clin Invest. 113:1202–1209. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shaul YD and Seger R: The MEK/ERK cascade:
from signaling specificity to diverse functions. Biochim Biophys
Acta. 1773:1213–1226. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cudaback E, Marrs W, Moeller T and Stella
N: The expression level of CB1 and CB2 receptors determines their
efficacy at inducing apoptosis in astrocytomas. PLoS One.
5:e87022010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Malfitano AM, Laezza C, Galgani M, et al:
The CB1 receptor antagonist rimonabant controls cell viability and
ascitic tumour growth in mice. Pharmacol Res. 65:365–371. 2012.
View Article : Google Scholar : PubMed/NCBI
|
